Recent developments, including a high-profile acquisition and key regulatory changes, point to a paradigm shift. Cell and gene therapy is becoming increasingly commercially viable, with the potential to improve the lives of millions.For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective […]
